Published in J Hepatol on July 01, 2000
Liver stem cells and hepatocellular carcinoma. Hepatology (2009) 2.27
Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol (2003) 2.27
Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology (2010) 2.03
Activation of stem cells in hepatic diseases. Cell Tissue Res (2007) 1.59
Recent progress on tissue-resident adult stem cell biology and their therapeutic implications. Stem Cell Rev (2008) 1.36
Stem cells in hepatocarcinogenesis: evidence from genomic data. Semin Liver Dis (2010) 1.02
Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology (2012) 0.98
Hepatic progenitor cells in human liver tumor development. World J Gastroenterol (2006) 0.98
The identification of stem cells in human liver diseases and hepatocellular carcinoma. Exp Mol Pathol (2010) 0.98
Disparate cellular basis of improved liver repair in beta-catenin-overexpressing mice after long-term exposure to 3,5-diethoxycarbonyl-1,4-dihydrocollidine. Am J Pathol (2010) 0.96
Immunohistochemical study of hepatic oval cells in human chronic viral hepatitis. World J Gastroenterol (2001) 0.95
The biology of cancer stem cells and its clinical implication in hepatocellular carcinoma. Gut Liver (2012) 0.93
Molecular pathogenesis of hepatic adenomas and its implications for surgical management. J Gastrointest Surg (2013) 0.86
Laminin induces the expression of cytokeratin 19 in hepatocellular carcinoma cells growing in culture. World J Gastroenterol (2003) 0.86
Scopolamine treatment and muscarinic receptor subtype-3 gene ablation augment azoxymethane-induced murine liver injury. J Pharmacol Exp Ther (2010) 0.84
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis. Oncotarget (2015) 0.84
Oval cell response is attenuated by depletion of liver resident macrophages in the 2-AAF/partial hepatectomy rat. PLoS One (2012) 0.83
Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. Mol Pathol (2001) 0.82
Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma. BMC Cancer (2014) 0.81
The expression of cytokeratin 19 in lymph nodes was a poor prognostic factor for hepatocellular carcinoma after hepatic resection. World J Surg Oncol (2013) 0.81
Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis. Int J Exp Pathol (2014) 0.80
Enhanced Wnt/β-catenin and Notch signalling in the activated canine hepatic progenitor cell niche. BMC Vet Res (2014) 0.78
Elevated CA19-9 Is Associated With Increased Mortality In A Prospective Cohort Of Hepatocellular Carcinoma Patients. Clin Transl Gastroenterol (2015) 0.77
Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma. Carcinogenesis (2016) 0.76
Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma. Oncol Lett (2012) 0.76
Primary combined hepatocellular-cholangiocellular sarcoma: An unusual case. World J Gastroenterol (2015) 0.76
Successful Interferon Therapy Reverses Enhanced Hepatic Progenitor Cell Activation in Patients with Chronic Hepatitis C. J Interferon Cytokine Res (2015) 0.75
The diversity and plasticity of adult hepatic progenitor cells and their niche. Liver Int (2017) 0.75
Histological grading and staging of chronic hepatitis. J Hepatol (1995) 19.57
Malignant angiomyolipoma of the liver: a hitherto unreported variant. Histopathology (2000) 3.24
Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone (1998) 2.18
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology (2006) 2.18
Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med (1994) 1.84
'Undifferentiated progenitor cells' in focal nodular hyperplasia of the liver. Histopathology (1996) 1.83
Recent advances in the separation and analysis of diazo-positive bile pigments. Methods Biochem Anal (1974) 1.81
Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumors. Cancer Genet Cytogenet (1993) 1.77
Primary liver tumour of intermediate (hepatocyte-bile duct cell) phenotype: a progenitor cell tumour? Liver (1998) 1.67
Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis. Gut (2008) 1.65
Incomplete septal cirrhosis: histopathological aspects. Histopathology (1988) 1.63
Alagille syndrome (arteriohepatic dysplasia) and del(20)(p11.2) Am J Med Genet (1990) 1.61
Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol (1990) 1.59
Immunopathology of trachomatous conjunctivitis. Br J Ophthalmol (1989) 1.59
Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J Hepatol (1998) 1.57
Renal involvement in sarcoidosis. Postgrad Med J (1970) 1.57
Nimesulide-induced acute hepatitis: evidence from six cases. J Hepatol (1998) 1.55
Bilirubin conjugates in bile of man and rat in the normal state and in liver disease. J Clin Invest (1972) 1.52
Histiocytes in Sweet's syndrome. Br J Dermatol (1991) 1.49
Idiopathic noncirrhotic portal hypertension is associated with poor survival: results of a long-term cohort study. Aliment Pharmacol Ther (2012) 1.49
Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology (2001) 1.46
Hepatic fibrogenesis requires sympathetic neurotransmitters. Gut (2004) 1.42
Embryology of extra- and intrahepatic bile ducts, the ductal plate. Anat Rec (Hoboken) (2008) 1.41
Ductular reaction in the liver. Pathol Res Pract (1995) 1.39
Case report 842. Benign hibernoma. Skeletal Radiol (1994) 1.39
Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol (2007) 1.33
Deep intralobular extension of human hepatic 'progenitor cells' correlates with parenchymal inflammation in chronic viral hepatitis: can 'progenitor cells' migrate? J Pathol (2000) 1.32
Pathologic aspects of a newly described nephropathy related to the prolonged use of Chinese herbs. Am J Kidney Dis (1994) 1.29
Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Pathol (2001) 1.29
Ductular reaction and its diagnostic significance. Semin Diagn Pathol (1998) 1.29
Intrahepatic bile duct development in the rat: a cytokeratin-immunohistochemical study. Lab Invest (1988) 1.27
Inflammatory myofibroblastic tumor of bone: report of two cases with evidence of clonal chromosomal changes. Am J Surg Pathol (1997) 1.24
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology (2001) 1.20
Ultrastructural characteristics of novel epithelial cell types identified in human pathologic liver specimens with chronic ductular reaction. Am J Pathol (1992) 1.16
Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol (1997) 1.15
A new methodology for teaching clinical reasoning skills: problem solving clinical seminars. Med Teach (2005) 1.14
Lymphocytes and Langerhans cells in the normal human cornea. Invest Ophthalmol Vis Sci (1985) 1.13
Xanthogranulomatous pyelonephritis with emphasis on computerized tomography scan. Retrospective study of 20 cases and literature review. Urology (1987) 1.13
Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside? Gut (2008) 1.12
Silicon nephropathy: a possible occupational hazard. Nephron (1980) 1.12
Synaptophysin: A novel marker for human and rat hepatic stellate cells. Am J Pathol (1999) 1.11
Squamous cell carcinoma antigen in human liver carcinogenesis. J Clin Pathol (2007) 1.10
Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review. Ann Oncol (2006) 1.10
Light chain deposition disease of the liver associated with AL-type amyloidosis and severe cholestasis. J Hepatol (1991) 1.07
Liver transplantation for polycystic liver disease. Liver Transpl (2001) 1.06
Heparan sulfate proteoglycan expression in normal human liver. Hepatology (1995) 1.06
Immunopathogenesis of conjunctival scarring in trachoma. Eye (Lond) (1998) 1.06
Autosomal dominant polycystic kidney disease in the neonatal period: association with a cerebral arteriovenous malformation. Pediatrics (1982) 1.06
Study of the usefulness and the limits of ultrasonic diagnostic criteria for diagnosis of liver tumours. Acta Gastroenterol Belg (1993) 1.06
Pericardial disease is often not recognised as a cause of chronic severe ascites. J Hepatol (2000) 1.05
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Clin Exp Immunol (1997) 1.05
Collagenous fibroma (desmoplastic fibroblastoma): genetic link with fibroma of tendon sheath? Mod Pathol (1999) 1.02
Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol (1998) 1.02
Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. Lab Invest (1985) 1.01
Cells with neuroendocrine features in regenerating human liver. APMIS Suppl (1991) 1.01
Value of carbon dioxide wedged venography and transvenous liver biopsy in the definitive diagnosis of Abernethy malformation. Abdom Imaging (2006) 1.01
A study of liver biopsies and liver disease among hemophiliacs. Blood (1985) 1.00
A cutaneous APUDoma or Merkel cell tumor? A morphologically recognizable tumor with a biological and histological malignant aspect in contrast with its clinical behavior. Cancer (1980) 1.00
Progressive intrahepatic cholestasis (Byler's disease): case report. Gut (1975) 1.00
Severe alport phenotype in a woman with two missense mutations in the same COL4A5 gene and preponderant inactivation of the X chromosome carrying the normal allele. J Clin Invest (1995) 1.00
Trisomy 7 and trisomy 8 in dividing and non-dividing tumor cells in Dupuytren's disease. Cancer Genet Cytogenet (1999) 0.99
Histopathology of portal hypertension: a practical guideline. Histopathology (2003) 0.98
Hepatocarcinoma-intestine-pancreas/pancreatic associated protein (HIP/PAP) is expressed and secreted by proliferating ductules as well as by hepatocarcinoma and cholangiocarcinoma cells. Am J Pathol (1999) 0.97
Expression of neural cell adhesion molecule in human liver development and in congenital and acquired liver diseases. Histochem Cell Biol (2001) 0.97
Cytidine monophosphate as substrate for the electron microscopic visualization of alkaline phosphatase activity. Histochemie (1967) 0.97
Submucosal tumors of the colon: experience with twenty-five cases. Dis Colon Rectum (1978) 0.96
Clinical fluorescence diagnosis of human bladder carcinoma following low-dose Photofrin injection. Urology (1993) 0.96
Histologic localization of PLAG1 (pleomorphic adenoma gene 1) in pleomorphic adenoma of the salivary gland: cytogenetic evidence of common origin of phenotypically diverse cells. Lab Invest (2001) 0.96
The effect of imatinib mesylate on the contractility of isolated rabbit myometrial strips. Gynecol Obstet Invest (2006) 0.95
[Histological course of diffuse proliferative glomerulonephritis treated with indomethacin]. J Urol Nephrol (Paris) (1970) 0.95
t(9;22)(q22-31;q11-12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Mod Pathol (1995) 0.95
Giant cell rich parosteal osteosarcoma. Histopathology (1995) 0.94
Histochemical study of rat liver in alpha-naphthyl isothiocyanate (ANIT) induced cholestasis. Am J Pathol (1968) 0.94
Tumorigenicity and interferon properties of the PLC/PRF/5 human hepatoma cell line. Prog Med Virol (1981) 0.94
Chronic renal failure due to renal hemosiderosis in a patient with paroxysmal nocturnal hemoglobinuria. Clin Nephrol (1993) 0.94
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeks. J Viral Hepat (2012) 0.94
Acute carpal tunnel syndrome caused by hydroxyapatite crystals: a case report. J Hand Surg Am (1996) 0.94
Nephronophthisis and tapetoretinal degeneration associated with liver fibrosis. Clin Nephrol (1975) 0.93
'Lupus' anticoagulant and thrombosis of the hepatic veins (Budd-Chiari syndrome). Report of three patients and review of the literature. J Hepatol (1986) 0.93
Epidermal Langerhans cells, dermal dendritic cells, and keratinocytes in viral lesions of skin and mucous membranes: an immunohistochemical study. Arch Dermatol Res (1988) 0.93
Fundus changes in membranoproliferative glomerulonephritis type II. A fluorescein angiographic study of 23 patients. Graefes Arch Clin Exp Ophthalmol (1991) 0.93
Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol (1991) 0.92
Pleuropulmonary blastoma (pulmonary blastoma of childhood): genetic link with other embryonal malignancies? Histopathology (1994) 0.92
New discriminative chromosomal marker in adipose tissue tumors. The chromosome 8q11-q13 region in lipoblastoma. Cancer Genet Cytogenet (1994) 0.92
Lymphocytes and Langerhans cells in the human oesophageal epithelium. Virchows Arch A Pathol Anat Histopathol (1983) 0.92